ISSN:

移植レポート : オープンアクセス

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Clinical Benefits of Renal Transplantation from Dead Recipients

Guihua Chen

Background and Objectives: Store shield plus could be a protective answer for cold organ storage, with a composition a twin of Institute Georges Lopez (IGL-1) answer. The aim of this single center study was to match the clinical performance of Store shield and with the generic counterpart of University of Wisconsin preservation fluid, named SPS-1. Materials and ways: The clinical outcomes of 168 consecutive organs preserved with Store shield and answer and 167 organs preserved with SPS-1 answer were compared. Throughout associate 18-month post-transplant follow-up amount, excretory organ graft perform, the frequency of acute rejection, post-transplant polygenic disease, and infectious complications, moreover as patient and graft survival were analyzed. Results: There was considerably a lot of immediate graft perform (IGF) (39.3 vs. 24.0%; p < 0.01) and fewer slow graft perform (SGF) (38.7 vs. 51.5%; p < 0.05) within the Store shield and cluster as compared with the SPS-1 cluster, whereas the incidence of DGF was similar in each teams. long excretory organ graft perform was comparable [1]. variable multivariate analysis showed that the employment of Store shield and vs. SPS-1 answer (rpartial = zero.217; p < 0.001) and therefore the quantity of residual symptom (rpartial = zero.147; p < 0.001) severally inflated the incidence of IGF, whereas Scr > one.5 mg/dL before organ procural (rpartial = −0.198; p < 0.001), longer CIT (rpartial = −0.170; p < 0.01), and CVD donor death (rpartial = −0.214; p < 0.001) were related to SGF. Conclusions: the upper incidence of IGF was found in excretory organ transplant recipients whose organs were preserved victimisation StoreProtect and answer as compared with SPS-1 answer. The 2 teams didn't dissent in excretory organ graft perform, the frequency of post-transplant complications, moreover as patient and graft survival [2].

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。